格隆汇10月9日丨根据联交所最新权益披露资料显示，2025年10月8日，石四药集团(02005.HK)获执行董事兼主席兼行政总裁曲继广在场内以每股均2.8633港 元增持200万股，涉资约572.66万港元。 | 表格序號 | 大股東/董事/最高行政人員名稱 作出披露的 買入 / 費出或涉及的股 每股的平均價 | | | | | 持有權益的股份數目 佔已發行的 有關事件的日 | | --- | --- | --- | --- | --- | --- | --- | | | | 原因 | 份數目 | | | (請參閱上述 * 註解)有投票權股 (日 / 月 / 年) | | | | | | | | 份自分比 | | | | | | | | ( % ) | | DA20251008E00348 | 曲缆层 | 1113(L) | | 2,000,000(L) | HKD 2.8633 | 1,209,792,000(L) 40.99(L)08/10/2025 | | 股份代號: | 02005 | | --- | --- | | 上市法國名稱: | 石四藥集國有限公司 | | 日期 (日 / 月 / 年): | ...

Core Viewpoint - The company, 石四药集团 (Sihuan Pharmaceutical Holdings Group Ltd), announced a share buyback of 2 million shares at a cost of HKD 5.727 million on October 8 [1] Group 1 - The total expenditure for the share buyback was HKD 5.727 million [1] - The number of shares repurchased was 2 million [1]

Core Viewpoint - The company, 石四药集团 (Sihuan Pharmaceutical Holdings Group Ltd), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will spend HKD 5.7266 million to repurchase 2 million shares [1] - The buyback is scheduled for October 8, 2025, reflecting a strategic move to enhance shareholder value [1]

Core Viewpoint - The company, Stone Four Pharmaceutical Group, announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will spend HKD 5.7266 million to repurchase 2 million shares [1]

FF305 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02005 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年10月6日 | | 2,919,613,385 | | 31,500,000 | | 2,951,113,385 | | 1). 購回股份 (股份被持作庫存股份) | | | -2,000,000 | 0.069 % | 2,000,000 HKD | 2.8633 | | | ...

Summary of Key Points Core Viewpoint - Multiple companies conducted share buybacks on October 6, 2025, with Tencent Holdings leading in both the number of shares repurchased and the total amount spent [1]. Group 1: Buyback Details - Tencent Holdings (00700) repurchased 815,000 shares for a total of 550 million [2]. - Hang Seng Bank (00011) repurchased 200,000 shares for 23.98 million [2]. - Mengniu Dairy (02319) repurchased 1 million shares for 14.41 million [2]. - Antonoil Oilfield Services (03337) repurchased 8.4 million shares for 9.99 million [2]. - Cloud Factory (N23027) repurchased 1.896 million shares for 9.17 million [2]. Group 2: Cumulative Buyback Data - Tencent Holdings has a cumulative buyback of 68.257 million shares, representing 0.743% of its total share capital [2]. - Hang Seng Bank has a cumulative buyback of 9.13 million shares, representing 0.485% of its total share capital [2]. - Mengniu Dairy has a cumulative buyback of 15.516 million shares, representing 0.397% of its total share capital [2]. - Antonoil Oilfield Services has a cumulative buyback of 10.5 million shares, representing 0.350% of its total share capital [2]. - Cloud Factory has a cumulative buyback of 10.24 million shares, representing 2.226% of its total share capital [2].

Core Viewpoint - The company, 石四药集团 (Stock Code: 02005), announced a share buyback plan, intending to repurchase 3 million shares at a cost of HKD 8.6989 million, scheduled for October 6, 2025 [1] Group 1 - The total amount allocated for the share buyback is HKD 8.6989 million [1] - The number of shares to be repurchased is 3 million [1] - The buyback is set to take place on October 6, 2025 [1]

Core Viewpoint - The company, Stone Four Pharmaceutical Group, announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will spend HKD 8.6989 million to repurchase 3 million shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 石四藥集團有限公司 呈交日期： 2025年10月6日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02005 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 石四藥集團有限公司 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02005 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.02 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.02 | HKD | | 200,000,000 | 本月底法定/ ...